C12M41/30

LARGE SCALE CELL GROWING DEVICES AND SYSTEMS
20200087604 · 2020-03-19 ·

A cell-growing system may include a cell-growing container, a pump for controlling the pressure of the chamber of the container, a filter for maintaining the chamber sterilized, a flow control regulator for controlling the substance supplied to the cell-growing container. The cell-growing container may include an internal structure that takes the form of a reticulated structure to increase the surface area for growing cells. The cell-growing system may be used to perform cycles of cell expansion and harvest. The cell-growing system may be maintained as a closed and sterilized system through the cycles. In harvesting, a first subset of the cells can be disassociated from the cell culture while a second subset remains. The disassociated cells may be discharged to a collection container while maintaining the system closed to an external environment. The remaining cells may be used as seeds to proliferate more cells in the next cycle.

METHOD AND SYSTEM FOR MONITORING AND CONTROLLING CONTINUOUS GAS FERMENTATION WITH BIOMARKERS
20240026275 · 2024-01-25 ·

Methods and systems to control continuous gas fermentation platforms for improved conversion of gas substrates into products is developed and particularly relates to a control process and system to control feedstock gases and maximize the bioreactor performance with biomarkers. Improved carbon utilization results through providing the most beneficial feed of substrates to the bioreactor of the fermentation process.

CHEMICAL ENGINEERING PROCESSES AND APPARATUS FOR THE SYNTHESIS OF COMPOUNDS

The present invention provides methods for producing cannabinoids and cannabinoid analogs as well as a system for producing these compounds. The inventive method is directed to contacting a compound according to Formula I or Formula II with a cannabinoid synthase.

##STR00001##

Also described is a system for producing cannabinoids and cannabinoid analogs by contacting a THCA synthase with a cannabinoid precursor and modifying at least one property of the reaction mixture to influence the quantity formed of a first cannabinoid relative to the quantity formed of a second cannabinoid.

METHODS OF PREPARING PERSONALIZED BLOOD VESSELS
20200038555 · 2020-02-06 · ·

The present disclosure relates to methods of preparing personalized blood vessels, useful for transplantation with improved host compatibility and reduced susceptibility to thrombosis. Also provided are personalized blood vessels produced by the methods and use thereof in surgery.

METHODS OF PREPARING PERSONALIZED BLOOD VESSELS
20200038556 · 2020-02-06 · ·

The present disclosure relates to methods of preparing personalized blood vessels, useful for transplantation with improved host compatibility and reduced susceptibility to thrombosis. Also provided are personalized blood vessels produced by the methods and use thereof in surgery.

CELL OBSERVATION APPARATUS
20200002661 · 2020-01-02 ·

There is provided a cell observation apparatus having a sterile chamber 3 containing a culture vessel 1 and a transparent observation window 11 provided in a bottom portion of the sterile chamber 3 and having the culture vessel 1 placed thereabove, wherein the camera 4 and the lighting 5 are provided below the observation window 11. The cells in the culture vessel 1 are imaged through the observation window 11 by setting the focus of the camera 4 to a bottom surface 1d of the culture vessel 1. The lighting 5 emits inspection light L as spot light where the light is not diffused, and an imaging range of the camera 4 is positioned inside an irradiation range of the inspection light L on the bottom surface 1d of the culture vessel 1.

APPARATUS, METHODS AND COMPOSITION FOR SYNTHESIS OF CANNABINOID COMPOUNDS

The disclosure provides systems and methods for producing a cannabinoid product, which comprises contacting a cannabinoid precursor in a first phase with a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible. The disclosure also provides a composition comprising the cannabinoid precursor in a first phase and a cannabinoid synthase in a second phase, wherein the first phase and the second phase are substantially immiscible or immiscible.

CONTINUOUS PRODUCTION METHOD OF MICROORGANISMS THAT DO NOT REQUIRE STERILIZATION AND SYSTEM THEREFOR

The objective of the present invention is to provide a method and a system for continuous production of microorganisms without the need for sterilization. The present invention provides a novel method for continuously producing microorganisms by proliferating a stored microorganism inoculum without the need for sterilization and a system therefor. According to the present invention, a novel method and system for producing microorganisms in which the need for sterilization for avoiding contamination with unwanted bacteria is reduced as compared with general methods and systems for producing microorganisms are provided.

Bioreactor Apparatus and Related Methods for Converting Carbon Dioxide to Oxygen
20240101941 · 2024-03-28 ·

The present disclosure provides a bioreactor that utilizes cultivated algae grown within a sealed chamber to convert carbon dioxide in fluid that is passed through the sealed chamber into oxygen via photosynthesis. The apparatus comprises an LED array for providing artificial light to the algae, which causes them to utilize CO2 in the surrounding fluid for photosynthesis, producing oxygen as a result. Transparent inserts are disposed within the sealed chamber for increasing the amount of surface area on which the algae can form and increasing efficiency.

METHOD IN BIOPROCESS PURIFICATION SYSTEM

The present invention relates to a method for controlling process parameters in a bioreactor when producing a target product with a pre-determined critical to quality, CTQ, profile. The method comprises: monitoring (S20) at least one product quality attribute, PQA, for the target product; identifying (S30) trends and/or deviations by comparing the monitored at least one PQA to the CTQ profile of the target product; and controlling (S40) process parameters of the bioreactor based on the identified trends and/or deviations to maintain the target product within the CTQ profile.